RAAS inhibitor use may reduce 3-year colorectal cancer risk in certain patients

Use of renin-angiotensin-aldosterone system, or RAAS, antagonists such as ACE inhibitors or angiotensin receptor blockers was linked to reduced risk for colorectal cancer in the 3 years after an index colonoscopy with negative diagnosis.For every year of ACE inhibitor or angiotensin receptor blocker use, researchers observed a 5% decrease in risk for colorectal cancer, up to 3 years.“While ACE inhibitors and angiotensin receptor blockers are taken by patients with high blood pressure, heart failure and kidney diseases, the reduction in colorectal cancer risk may be an additional factorRead More

Share on facebook
Share on twitter
Share on linkedin